AI assistant
Sending…
AGENUS INC — Director's Dealing 2017
Apr 4, 2017
34023_dirs_2017-04-04_8c3baf3f-ca2f-4e32-a2b0-018aa8357053.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (agen)
CIK: 0001098972
Period of Report: 2017-03-31
Reporting Person: ARMEN GARO H (Chairman and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | Restricted Stock Unit | $ | A | 647000 | Acquired | 2022-03-31 | Common Stock (647000) | Direct |
| 2017-03-31 | Stock Option, Right to Buy | $3.77 | A | 853000 | Acquired | 2027-03-31 | Common Stock (853000) | Direct |
Footnotes
F1: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date.
F2: Option vests 100% on 5-year anniversary of the award provided Dr. Armen maintains a service relationship with the Company on such date.
More from AGENUS INC
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Legal Proceedings Report
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23